Advertisement
UK markets close in 2 hours 37 minutes

  • FTSE 100

    8,329.74
    +16.07 (+0.19%)
     

  • FTSE 250

    20,387.55
    -25.53 (-0.13%)
     

  • AIM

    777.16
    +0.74 (+0.10%)
     

  • GBP/EUR

    1.1612
    -0.0012 (-0.10%)
     

  • GBP/USD

    1.2482
    -0.0028 (-0.22%)
     

  • Bitcoin GBP

    49,839.02
    -1,190.38 (-2.33%)
     

  • CMC Crypto 200

    1,320.61
    +25.93 (+2.00%)
     

  • S&P 500

    5,187.70
    +6.96 (+0.13%)
     

  • DOW

    38,884.26
    +31.99 (+0.08%)
     

  • CRUDE OIL

    77.41
    -0.97 (-1.24%)
     

  • GOLD FUTURES

    2,322.60
    -1.60 (-0.07%)
     

  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     

  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     

  • DAX

    18,437.27
    +7.22 (+0.04%)
     

  • CAC 40

    8,124.89
    +49.21 (+0.61%)
     
Money:

How to make a tax-free income

Tips for making money that won't be taxed

AstraZeneca to invest $285 mln in Swedish biotech factory

Reuters - UK Focus

LONDON, May 18 (Reuters) - AstraZeneca (NYSE: AZN - news) is investing $285 million to expand biotech drug manufacturing in Sweden as the company bets on the future of high-tech medicine for future growth.

The new facility for biological medicines in Sodertalje will supply medicines for clinical trial programmes from the end of 2018 and will deliver finished products for commercial use once fully operational by 2019.

The planned investment will, subject to relevant approvals by the local authorities, create between 150 and 250 highly skilled new roles at AstraZeneca by 2019, the Anglo-Swedish company said in a statement on Monday.

The new plant will be focused on filling and packaging of protein therapeutics.

(Reporting by Ben Hirschler, editing by Louise Heavens)